trametinib
Ligand Summary
a reversible inhibitor of mitogen-activated extracellular signal-regulated kinase 1 (MEK1) and MEK2 activation and of MEK1 and MEK2 kinase activity. MEK proteins are upstream regulators of the extracellular signal-related kinase (ERK) pathway, which promotes cellular proliferation
UNII: 33E86K87QN
PubChem: 11707110
Guide to Pharmacology: 6495
ChEMBL: CHEMBL2103875
DrugCentral: 4802
LyCHI: T5HZJQ4ZPZ9W
Target Activities
10 Activities
Items per page:
1 – 10 of 10
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | ||||||
IC50 | ||||||
Kd | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
EC50 | ||||||
IC50 | INHIBITOR | |||||
IC50 | INHIBITOR | |||||
EC50 | ||||||